反応式
[CH3:1][C:2]1[N:6]([CH2:7][C:8]([N:10]2[CH2:15][CH2:14][CH:13]([C:16]3[S:17][CH:18]=[C:19]([C:21]#[C:22][C:23]4[C:32]5[C:27](=[CH:28][CH:29]=[CH:30][CH:31]=5)[CH:26]=[CH:25][CH:24]=4)[N:20]=3)[CH2:12][CH2:11]2)=[O:9])[N:5]=[C:4]([C:33]([F:36])([F:35])[F:34])[CH:3]=1>CO.C([O-])=O.[NH4+].[OH-].[OH-].[Pd+2]>[CH3:1][C:2]1[N:6]([CH2:7][C:8]([N:10]2[CH2:11][CH2:12][CH:13]([C:16]3[S:17][CH:18]=[C:19]([CH2:21][CH2:22][C:23]4[C:32]5[C:27](=[CH:28][CH:29]=[CH:30][CH:31]=5)[CH:26]=[CH:25][CH:24]=4)[N:20]=3)[CH2:14][CH2:15]2)=[O:9])[N:5]=[C:4]([C:33]([F:36])([F:34])[F:35])[CH:3]=1参加物
5
反応物 1
生成物 1
試薬・触媒・溶媒 3
実験手順
2-[5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(naphthalen-1-ylethynyl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone (I-50, 157 mg) is dissolved in methanol (1.5 ml) and, at 60° C., reacted with ammonium formiate (195 mg) and 20% Pd(OH)2/C (4 mg) as catalyst. The catalyst is filtered off and the solvent is removed under reduced pressure, giving 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[2-(naphthalen-1-yl)ethyl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (86 mg) as a colourless oil.
後処理
- filtrationThe catalyst is filtered off
- customthe solvent is removed under reduced pressure
出典と根拠
- ORDレコード
- ord-a22797a269504ad98967f5edf45ce244
- 出典データセット
- uspto-grants-2011_05
- 特許番号
- US07943774B2
関連ノート
読み込み中…